Related Experiment Video
Updated: Aug 14, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
Hemodialysis access in 2026: What the vascular medicine provider should know
Helena Smith1, Mohamad A Hussain2,3, Eric A Secemsky1,3,4
1Richard A and Susan F Smith Center for Outcomes Research, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Abstract:
Hemodialysis is the primary renal replacement therapy in the US for patients with end-stage kidney disease (ESKD). Functioning vascular access, in the form of an arteriovenous fistula (AVF) or graft (AVG), is fundamental to the outcomes for these patients. Over the last decade, changes have occurred in the field of vascular access. Evolving guidelines have placed unprecedented emphasis on individualized access, and rapid innovation-particularly in endovascular technologies-has expanded the toolkit for access creation and maintenance. This narrative review offers vascular medicine providers an in-depth evaluation of contemporary practice relating to hemodialysis access, including a comprehensive review of emerging technologies expected to shape the future of hemodialysis care.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Continuous Renal Replacement Therapy
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Peritoneal Dialysis III: Nursing Management
